The Older Cancer Patient

Medical Clinics of North America

Volumn 90, Issue 5, 2006, Pages 967-982

  White, Heidi K ^a,b   Cohen, Harvey J ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; HORMONE; PROTECTIVE AGENT; PSYCHOSTIMULANT AGENT; RAZOXANE;

AGE; AGING; ANEMIA; BREAST CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CARDIOTOXICITY; COMORBIDITY; CONVERSATION; DOCTOR PATIENT RELATION; EXERCISE; FRAIL ELDERLY; FUNCTIONAL DISEASE; GERIATRIC CARE; GERIATRIC PATIENT; HUMAN; OUTCOME ASSESSMENT; PAIN; PATIENT CARE PLANNING; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SYMPTOM; TERMINAL CARE; TREATMENT PLANNING; UTERUS CANCER;

AGED; COMBINED MODALITY THERAPY; GERIATRIC ASSESSMENT; HUMANS; NEOPLASMS; PALLIATIVE CARE; PATIENT CARE TEAM; PROGNOSIS; TERMINAL CARE;

EID: 33748471162     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2006.05.017     Document Type: Review

References (58)

1. Balducci L., and Repetto L. Increased risk of myelotoxicity in elderly patients with Non-Hodgkin Lymphoma: The case for routine prophylaxis with colony-stimulating factor beginning in the first cycle of chemotherapy. Cancer 100 1 (2004) 6-11
2. Lindeman R.D., Tobin J., and Shock N.W. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33 (1985) 278-285
3. United States Corporate Athletic Association. Marathon Records by Age Group. Available at http://www.uscaa.org/marathon/records.htm. Accessed April 15, 2006.
4. Jacobson S.D., Cha S., Sargent D.J., et al. Tolerability, dose intensity and benefit of 5FU based chemotherapy for advanced colorectal cancer (CRC) in the elderly. Proc Am Soc Clin Oncol 20 (2001) 384a, abstract 1534
5. Wasil T., and Lichtman S.M. Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy in the elderly. Oncologist 10 (2005) 602-612
6. O'Mahoney M.S., George G., Westlake H., et al. Plasma aspirin esterase activity in elderly patients undergoing elective hip replacement and with fractured neck of femur. Age Ageing 23 (1994) 338-341
7. Wynne H.A., Cope L.H., Herd B., et al. The association of age and frailty with paracetamol conjugation in man. Age Ageing 19 (1990) 419-424
8. Jacobs J.R., Reves J.G., Marty J., et al. Aging increases pharmacodynamic sensitivity to the hypnotic effects of midazolam. Anesth Analg 80 (1995) 143-148
9. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6 (2005) 611-622
10. Cohen H.J. Oncology and aging: general principles of cancer in the elderly. In: Hazzard W.R., Blass J.P., Halter J.B., et al. (Eds). Principles of geriatric medicine and gerontology. 5th edition (2003), McGraw-Hill, New York 673-675
11. Balducci L., and Extermann M. Management of cancer in the older person: a practical approach. Oncologist 5 (2000) 224-237
12. Extermann M., Aapro M., Bernabei R., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology. Crit Rev Oncol Hem 55 (2005) 241-252
13. Solomon D., Brown A.S., Brummel-Smith K., et al. National Institutes of Health Consensus Development Conference statement: geriatric assessment methods for clinical decision-making. J Am Geriatr Soc 36 (1988) 342-347
14. Stuck A.E., Siu A.L., Wieland G.D., et al. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 342 (1993) 1032-1036
15. Stuck A.E., Egger M., Hammer A., et al. Home visits to prevent nursing home admission and functional declinein elderly people: systematic review and meta-regression analysis. JAMA 287 (2002) 1022-1028
16. Reuben D.B., Frank J.C., Hirsch S.H., et al. A randomized clinical trial of outpatient comprehensive geriatric assessment coupled with an intervention to increase adherence to recommendations. J Am Geriatr Soc 47 3 (1999) 269-276
17. Cohen H.J., Feussner J.R., Weinberger M., et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med 346 (2002) 905-912
18. Rich M.W., Beckham V.T., Wittenburg C., et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333 (1995) 1190-1195
19. Rao A.V., Hsieh F., Feussner J.R., et al. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol: Med Sci 60A (2005) 798-803
20. Ingram S.S., Seo P.H., Martell R.E., et al. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol 20 3 (2002) 770-775
21. Hurria A., Gupta S., Zauderer M., et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 104 (2005) 1998-2005
22. Extermann M., Meyer J., Mcginnis M., et al. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol 49 (2004) 69-75
23. Yancik R., Wesley M.N., Ries L.A., et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 82 11 (1998) 2123-2134
24. Yancik R., Wesley M.N., Ries L.A., et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285 7 (2001) 885-892
25. Passick S.D., Dugan W., McDonald M.V., et al. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 16 4 (1998) 1594-1600
26. Chodosh J., Petitti D.B., Elliot M., et al. Physician recognition of cognitive impairment: evaluating the need for improvement. J Am Geriatr Soc 52 7 (2004) 1051-1059
27. Extermann M., Overcash J., Lyman G.H., et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16 4 (1998) 1582-1587
28. Repetto L., Fratino L., Audisio R.A., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 20 2 (2002) 494-502
29. Fried L.P., Tangen C.M., Walston J., et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56 3 (2001) M146-M156
30. Ferrucci L., Guralnik J.M., Cavazzini C., et al. The frailty syndrome: a critical issue in geriatric oncology. Crit Rev Oncol Hematol 46 (2003) 127-137
31. Balducci L., and Stanta G. Cancer in the frail patient: a coming epidemic. Hematol Oncol Clin North Am 14 (2000) 235-250
32. Audisio R.A., Osman N., Audisio M.M., et al. How do we manage breast cancer in the elderly patients? A survey among members of the British Association of Surgical Oncologists. Crit Rev Oncol Hematol 52 (2004) 135-141
33. Biganzoli L., Goldhirsch A., Straehle C., et al. Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the British International Group. Annal Oncol 15 (2004) 207-210
34. Saliba D., Elliott M., Rubenstein L.Z., et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 49 12 (2001) 1691-1699
35. Monson K., Litvak D.A., and Bold R.J. Surgery in the aged population: surgical oncology. Arch Surg 138 10 (2003) 1061-1067
36. Muss H., Woolf S., Berry D., et al. Cancer and leukemia group B. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293 9 (2005) 1073-1081
37. Rose J.H., O'Toole E.E., Dawson N.V., et al. Perspectives, preferences, care practices, and outcomes among older and middle-aged patients with late-stage cancer. J Clin Oncol 22 24 (2004) 4907-4917
38. Rao A., and Cohen H.J. Symptom management in the elderly cancer patient: fatigue, pain, and depression. J Natl Cancer Inst Monogr 32 (2004) 150-157
39. Bukberg J., Penman D., and Holland J.C. Depression in hospitalized cancer patients. Psychosom Med 46 (1984) 199-212
40. Hopwood P., and Stephens R.J. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 18 4 (2000) 893-903
41. Cassileth B.R., Lusk E.J., Brown L.L., et al. Factors associated with psychological distress in cancer patients. Med Pediatr Oncol 14 (1986) 251-254
42. Roberts R.E., and Vernon S.W. The Center for Epidemiologica Studies Depression Scale: its use in a community sample. Am J Psychiatry 140 (1983) 41-46
43. Montorio I., and Izal M. The Geriatric Depression Scale: a review of its development and utility. Int Psychogeriatr 8 (1996) 103-112
44. Koenig H.G., Cohen H.J., Blazer D.G., et al. A brief depression scale for use in the medically ill. Int J Psychiatry Med 22 (1992) 183-195
45. Demark-Wahnefried W., Morey M.C., Clipp E.C., et al. Leading the way in exercise and diet (Project LEAD): intervening to improve function among older breast and prostate cancer survivors. Control Clin Trials 24 (2003) 206-223
46. Demark-Wahnefried W., Aziz N.M., Rowland J.H., et al. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23 24 (2005) 5814-5830
47. Ingram S.S., Seo P.H., Sloane R., et al. The association between oral health and general health and quality if life in older male cancer patients. J Am Geriatr Soc 53 (2005) 1504-1509
48. Hewitt M., Rowland J.H., and Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 58 1 (2003) 82-91
49. Clipp E.C., Hollis D.R., and Cohen H.J. Considerations of psychosocial illness phase in cancer survival. Psychooncology 10 2 (2001) 166-178
50. Haley W.E. The costs of family caregiving: implications for geriatric oncology. Crit Rev Oncol Hematol 48 2 (2003) 151-158
51. Sutton L.M., Demark-Wahnefried W., and Clipp E.C. Management of terminal cancer in elderly patients. Lancet Oncol 4 3 (2003) 149-157
52. Lewis J.H., Kilgore M.L., Goldman D.P., et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21 (2003) 1383-1389
53. Kemeny MM, Peterson BL, Kornblith AB, et al. Wheeler J. Levine E. Bartlett N. Fleming G. Cohen HJ. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 2003;21(12):2268-75.
54. Kornblith A.B., Kemeny M., Peterson B.L., et al. Cancer and leukemia group B. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 95 5 (2002) 989-996
55. Yancik R. Integration of aging and cancer research in geriatric medicine. J Gerontol A Biol Sci Med Sci 52 6 (1997) M329-M332
56. Balducci L. Geriatric oncology. Crit Rev Oncol Hematol 46 (2003) 211-220
57. Monfardini S. Geriatric oncology: a new subspecialty?. J Clin Oncol 22 22 (2004) 4655
58. Mathias S., Nayak U.S., and Isaacs B. Balance in elderly patients: the "get-up and go" test. Arch Phys Med Rehabil 67 6 (1986) 387-389